Keywords: bayer, offers, license, opportunity, seeking, exclusive, licensee

Bayer offers license opportunity

Article | 29 April 2002

Print This

Bayer is seeking an exclusive licensee for its end-of-Phase I progestinagonist Bay 39-9624.

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in